这不仅是对企业科创实力的印证，更折射出中国医疗科技从"引进来"到"自主创新"、从"跟跑"到"领 跑"的发展路径。 60%首发首展锚定四大场景 "今年进博会的AI应用已从单点工具升级为系统方案，我们超60%的首发首展成果正是对这一趋势的精 准回应。"盈康一生相关负责人表示，从早年突破-86℃超低温冰箱核心技术、打破外资长达三十年的垄 断，到如今60%首发首展，盈康一生的每一次技术跨越，都是新质生产力在医疗领域的生动实践。 在"未来科研"场景，爱德蒙生物样本数智管理方案与超速离心机等原创产品吸引了专业观众的目光。现 场技术人员演示着在操作屏上简单指令，即可实现样本的批量识别与精准定位。传统人工盘点需开门操 作，存在风险且效率低，如今，设备搭载了原创的-86℃超低温下NAIT技术，不开门仅需5秒即可完成 自动盘点，存取流程由9步简化为2步，极大提升了科研管理效率。 "今年进博会的AI应用已从单点工具升级为系统方案，我们超60%的首发首展成果正是对这一趋势的精 准回应。"盈康一生相关负责人表示，从"展品首秀"走向"生态落地"，进博会见证了我们从"设备供应 商"向"场景服务商"的转型。 在"未来医院"场景，盈康一生以人 ...

AI赋能，引领未来：60%首发首展锚定四大场景 "今年进博会的AI应用已从单点工具升级为系统方案，我们超60%的首发首展成果正是对这一趋势的精准回 应。"盈康一生相关负责人表示。 在"未来科研"场景，爱德蒙生物样本数智管理方案与超速离心机等原创产品吸引了专业观众的目光。传统人工盘 点需开门操作，存在风险且效率低，如今，设备搭载了原创的-86℃超低温下NAIT技术，不开门仅需5秒即可完 成自动盘点，存取流程由9步简化为2步，极大提升了科研管理效率。 十万转超速离心机&爱德蒙生物样本数智管理方案 转自：新华财经 11月5日，第八届中国国际进口博览会在上海启幕。海尔集团旗下大健康生态品牌盈康一生连续六年参展，以"AI in Care·因AI盈康"为主题，携未来科研、未来医院、生态创新、全球在地化四大场景解决方案亮相，更以30多项 产品与方案，60%首发首展，成为展区中备受瞩目的"中国创新代表"。 盈康一生展区 "从'展品首秀'走向'生态落地'，进博会见证了我们从'设备供应商'向'场景服务商'的转型。"盈康一生相关负责人 在开展仪式上表示。这不仅是对企业科创实力的印证，更折射出中国医疗科技从"引进来"到"自主创新"、 ...

Core Insights - The article emphasizes the importance of leveraging AI technology to enhance the growth and ecosystem of companies, particularly in the healthcare sector, as demonstrated by Haier Group's subsidiary, YK Life [1][6][10] Group 1: AI Integration in Healthcare - YK Life has transitioned from merely showcasing AI products to creating comprehensive healthcare ecosystems that integrate both hospital and outpatient services [2][5] - The company utilizes AI for patient-centered care, enhancing the entire medical process from pre-diagnosis to post-treatment management [2][3] - AI technologies, such as digital mammography and automated drug preparation systems, are being implemented to improve diagnostic accuracy and treatment efficiency [3][8] Group 2: Global Expansion and Market Reach - YK Life has established a presence in over 160 countries, serving more than 100 million users through localized strategies and tailored healthcare solutions [1][11] - The company has developed a global market strategy that combines customized products with localized operations to address diverse public health needs [11] Group 3: Strategic Positioning and Ecosystem Development - YK Life's early and comprehensive strategic planning in AI has positioned it as a leader in the healthcare sector, collaborating with industry leaders to enhance its AI capabilities [6][7] - The company aims to break down data silos in the healthcare industry by creating interconnected ecosystems that facilitate information sharing across different sectors [3][9] Group 4: Future Prospects and Innovations - The ongoing AI-driven transformation in life sciences is seen as a complex system that requires an open and collaborative ecosystem for successful implementation [10] - YK Life is focused on integrating AI across the entire healthcare value chain, from research and development to clinical applications, thereby enhancing operational efficiency and patient care [9][10]